Surgery Medical News about Cholangitis, Sclerosing

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Surveillance and Screening of Primary Sclerosing Cholangitis
Digestive Diseases, 11/09/09

Gerken G et al. – Primary sclerosing cholangitis (PSC) represents an idiopathic chronic cholestatic liver disease due to inflammatory destruction of the biliary tree. Clinically, the progressive disease leads to biliary cirrhosis in association with cholangiocarcinoma in 6–20% of the patients. Currently, liver transplantation remains the only life–extending treatment option in end–stage disease.

<< Previous
Interventional oncology: new options for interstitial treatments...

Next >>
Impact of mesh positioning on foreign body reaction and...

Primary Sclerosing Cholangitis: A Clinical Case
Digestive Diseases, 11/09/09 Relevance Score: 68%

Prediction of Graft Loss and Death in Patients With Primary Sclerosing Cholangitis
Transplantation Proceedings, 11/10/09 Relevance Score: 67%

Chemotherapy-induced sclerosing cholangitis as a rare indication for resection: Report of a case
Surgery Today, 10/06/09 Relevance Score: 67%

Lymphoplasmacytic sclerosing cholangitis: assessment of clinical, CT, and pathological findings
Clinical Radiology, 10/19/09 Relevance Score: 66%

Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis
Hepatology, 11/02/09 Relevance Score: 63%